Circulating visfatin level is correlated with inflammation, but not with insulin resistance
- PMID: 17634078
- DOI: 10.1111/j.1365-2265.2007.02966.x
Circulating visfatin level is correlated with inflammation, but not with insulin resistance
Abstract
Objective: Recent studies, both in vitro and in vivo, have indicated that visfatin is one of the inflammatory cytokines, although the relationship between visfatin and insulin resistance remains inconclusive. Accordingly, we assessed the association between visfatin concentrations in serum and those of interleukin-6 (IL-6) and C-reactive protein (CRP), known as markers of systemic inflammation, and also investigated the relationship between these serum concentrations and insulin resistance.
Design and method: A total of 295 Japanese Americans living in Hawaii (126 men and 169 women, mean age 68.7 +/- 14.9 years) were enrolled. The serum levels of visfatin, IL-6 and CRP levels were measured, and homeostasis model assessment for insulin resistance (HOMA-IR) was calculated as a marker of insulin resistance.
Results: Significant positive correlations were found between serum levels of visfatin and IL-6 or CRP (r = 0.271, P < 0.001; r = 0.118, P < 0.05, respectively). Multiple regression analysis revealed that correlations between serum levels of visfatin and IL-6 or CRP remained significant after adjustments for age, sex, body mass index, per cent body fat and waist girth. There was no significant trend of the HOMA-IR for the tertiles of serum concentrations of visfatin. On the other hand, a significant trend towards increase of HOMA-IR with increasing tertile of serum concentrations, from the lowest to the highest, was observed for both IL-6 and CRP. The HOMA-IR in subjects with serum concentration of IL-6 or CRP in the highest or intermediate tertiles of IL-6 or CRP were significantly higher than that in subjects in the lowest tertile, even after adjustment for age and sex (IL-6: P < 0.001 and P < 0.001, respectively; CRP: P < 0.001 and P < 0.01, respectively).
Conclusion: Serum visfatin levels were positively correlated with the serum levels of IL-6 and slightly related with serum levels of CRP, but not with HOMA-IR, in Japanese Americans. Our results indicate that circulating visfatin may reflect inflammation status.
Similar articles
-
Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.Clin Endocrinol (Oxf). 2009 Nov;71(5):733-8. doi: 10.1111/j.1365-2265.2009.03546.x. Epub 2009 Feb 16. Clin Endocrinol (Oxf). 2009. PMID: 19222486
-
Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).Metabolism. 2006 Sep;55(9):1232-8. doi: 10.1016/j.metabol.2006.05.008. Metabolism. 2006. PMID: 16919544
-
Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.Saudi Med J. 2008 Feb;29(2):185-92. Saudi Med J. 2008. PMID: 18246224
-
Visfatin in pregnancy: proposed mechanism of peptide delivery.Amino Acids. 2009 Oct;37(4):555-8. doi: 10.1007/s00726-008-0194-7. Epub 2008 Oct 25. Amino Acids. 2009. PMID: 18953631 Review.
-
Serum C-reactive protein as a marker for wellness assessment.Ann Clin Lab Sci. 2006 Spring;36(2):163-9. Ann Clin Lab Sci. 2006. PMID: 16682512 Review.
Cited by
-
Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.J Pers Med. 2022 May 1;12(5):735. doi: 10.3390/jpm12050735. J Pers Med. 2022. PMID: 35629157 Free PMC article.
-
Sirtuins and pyridine nucleotides.Circ Res. 2012 Aug 17;111(5):642-56. doi: 10.1161/CIRCRESAHA.111.246546. Circ Res. 2012. PMID: 22904043 Free PMC article. Review.
-
Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer.Front Physiol. 2022 Feb 17;13:819145. doi: 10.3389/fphys.2022.819145. eCollection 2022. Front Physiol. 2022. PMID: 35250621 Free PMC article. Review.
-
Serum visfatin levels do not increase in post-menopausal women with metabolic syndrome.J Endocrinol Invest. 2013 Mar;36(3):157-61. doi: 10.1007/BF03346752. J Endocrinol Invest. 2013. PMID: 23538464
-
Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH.Clin Mol Hepatol. 2012 Sep;18(3):279-86. doi: 10.3350/cmh.2012.18.3.279. Epub 2012 Sep 25. Clin Mol Hepatol. 2012. PMID: 23091808 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous